The effect of parathyroid hormone and teriparatide on fracture healing

Bibliography

• Hanley DA, Watson PM, Hodsman AB, Dempster DM. Pharmacologic mechanisms of therapeutics: parathyroid hormone. In: Bilezikian JP, Raisz LG, Martin TJ, editors. Principles of bone biology. 3rd Edition. Chapter 78 Academic Press, Elsevier; Amsterdam, The Netherlands: 2008. p. 1661-95
   Google Scholar
• Quattrocchi E, Kourlas H. Teriparatide: a review. Clin Ther 2004;26:841-54
   PubMed Web of Science ®Google Scholar
• McSheehy PM, Chambers TJ. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology 1986;118:824-8
   PubMed Web of Science ®Google Scholar
• Lewiecki EM, Miller PD. Skeletal effects of primary hyperparathyroidism: bone mineral density and fracture risk. J Clin Densitom 2013;16:28-32
   PubMed Web of Science ®Google Scholar
• Hock JM, Gera I. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J Bone Miner Res 1992;7:65-72
   PubMed Web of Science ®Google Scholar
• Parfitt AM. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part III of IV parts; PTH and osteoblasts, the relationship between bone turnover and bone loss, and the state of the bones in primary hyperparathyroidism. Metab Clin Exp 1976;25:1033-69
   PubMed Web of Science ®Google Scholar
• Rubin MR, Bilezikian JP. New anabolic therapies in osteoporosis. Endocrinol Metab Clin North Am 2003;32:285-307
   PubMed Web of Science ®Google Scholar
• Friedl G, Turner RT, Evans GL, Dobnig H. Intermittent parathyroid hormone (PTH) treatment and age-dependent effects on rat cancellous bone and mineral metabolism. J Orthop Res 2007;25:1454-64
   PubMed Web of Science ®Google Scholar
• Jilka RL. Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 2007;40:1434-46
   PubMed Web of Science ®Google Scholar
• Drake MT, Srinivasan B, Mödder UI, et al. Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women. J Clin Endocrinol Metab 2010;95:5056-62
   PubMed Web of Science ®Google Scholar
• Reeve J, Meunier PJ, Parsons JA, et al. Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. Br Med J 1980;280:1340-4
   PubMed Web of Science ®Google Scholar
• Dempster DW, Cosman F, Kurland ES, et al. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 2001;16:1846-53
   PubMed Web of Science ®Google Scholar
• Hansen S, Hauge EM, Beck Jensen J-E, Brixen K. Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT. J Bone Miner Res 2013;28:736-45
   PubMed Web of Science ®Google Scholar
• Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434-41
   PubMed Web of Science ®Google Scholar
• Greenspan SL, Bone HG, Ettinger MP, et al. Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann Intern Med 2007;146:326-39
   PubMed Web of Science ®Google Scholar
• Orwoll ES, Scheele WH, Paul S, et al. The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis. J Bone Miner Res 2003;18:9-17
   PubMed Web of Science ®Google Scholar
• Lane NE, Sanchez S, Modin GW, et al. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. J Clin Invest 1998;102:1627-33
   PubMed Web of Science ®Google Scholar
• Orwoll ES, Shapiro J, Veith S, et al. Evaluation of teriparatide treatment in adults with osteogenesis imperfecta. J Clin Invest 2014;124:491-8
   PubMed Web of Science ®Google Scholar
• Einhorn TA. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 1998(355 Suppl):S7-21
   PubMed Web of Science ®Google Scholar
• Barnes GL, Kostenuik PJ, Gerstenfeld LC, Einhorn TA. Growth factor regulation of fracture repair. J Bone Miner Res 1999;14:1805-15
   PubMed Web of Science ®Google Scholar
• McKibbin B. The biology of fracture healing in long bones. J Bone Joint Surg Br 1978;60-B:150-62
   PubMed Web of Science ®Google Scholar
• Simmons DJ. Fracture healing perspectives. Clin Orthop Relat Res 1985(200):100-13
   PubMed Web of Science ®Google Scholar
• Hankenson KD, Zimmerman G, Marcucio R. Biological perspectives of delayed fracture healing. Injury 2014;45:S8-S15
   PubMed Web of Science ®Google Scholar
• Snyder RA, Koester MC, Dunn WR. Epidemiology of stress fractures. Clin Sports Med 2006;25:37-52
   PubMed Web of Science ®Google Scholar
• Fields KB. Running injuries - changing trends and demographics. Curr Sports Med Rep 2011;10:299-303
   PubMed Web of Science ®Google Scholar
• Breer S, Krause M, Marshall RP, et al. Stress fractures in elderly patients. Int Orthop 2012;36:2581-7
   PubMed Web of Science ®Google Scholar
• Warden SJ, Burr DB, Brukner PD. Stress fractures: pathophysiology, epidemiology, and risk factors. Curr Osteoporos Rep 2006;4:103-9
   PubMedGoogle Scholar
• Pepper M, Akuthota V, McCarty EC. The Pathophysiology of stress fractures. Clin Sports Med 2006;25:1-16
   PubMed Web of Science ®Google Scholar
• Mattila VM, Niva M, Kiuru M, Pihlajam Ki H. Risk factors for bone stress injuries: a follow up study of 102,515 person-years. Med Sci Sports Exerc 2007;39:1061-6
   PubMed Web of Science ®Google Scholar
• Marx RG, Saint-Phard D, Callahan LR, et al. Stress fracture sites related to underlying bone health in athletic females. Clin J Sport Med 2001;11:73-6
   PubMed Web of Science ®Google Scholar
• Royer M, Thomas T, Cesini J, Legrand E. Stress fractures in 2011: practical approach. Joint Bone Spine 2012;79:S86-90
   Google Scholar
• Pegrum J, Crisp T, Padhiar N, Flynn J. The pathophysiology, diagnosis, and management of stress fractures in postmenopausal women. Phys Sportsmed 2012;40:32-42
   PubMed Web of Science ®Google Scholar
• Shane E, Burr D, Abrahamsen B, et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the american society for bone and mineral research. J Bone Miner Res 2014;29:1-23
   PubMed Web of Science ®Google Scholar
• Isaacs JD, Shidiak L, Harris IA, Szomor ZL. Femoral Insufficiency Fractures Associated with Prolonged Bisphosphonate Therapy. Clin Orthop Relat Res 2010;468:3384-92
   PubMed Web of Science ®Google Scholar
• Sloan AV, Martin JR, Li S, Li J. Parathyroid hormone and bisphosphonate have opposite effects on stress fracture repair. Bone 2010;47:235-40
   PubMed Web of Science ®Google Scholar
• Kakar S, Einhorn TA, Vora S, et al. Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures. J Bone Miner Res 2007;22:1903-12
   PubMed Web of Science ®Google Scholar
• Gaston MS, Simpson AH. Inhibition of fracture healing. J Bone Joint Surg Br 2007;89:1553-60
   PubMed Web of Science ®Google Scholar
• Hayda RA, Brighton CT, Esterhai JL. Pathophysiology of delayed healing. Clin Orthop Relat Res 1998(355 Suppl):S31-40
   Google Scholar
• Aho AJ. Electron microscopic and histological observations on fracture repair in young and old rats. Acta Pathol Microbiol Scand 1966(Suppl 184):1-95
   PubMedGoogle Scholar
• Meyer RA, Tsahakis PJ, Martin DF, et al. Age and ovariectomy impair both the normalization of mechanical properties and the accretion of mineral by the fracture callus in rats. J Orthop Res 2001;19:428-35
   PubMed Web of Science ®Google Scholar
• Macey LR, Kana SM, Jingushi S, et al. Defects of early fracture-healing in experimental diabetes. J Bone Joint Surg Am 1989;71:722-33
   PubMed Web of Science ®Google Scholar
• Beam HA, Parsons JR, Lin SS. The effects of blood glucose control upon fracture healing in the BB Wistar rat with diabetes mellitus. J Orthop Res 2002;20:1210-16
   PubMed Web of Science ®Google Scholar
• Funk JR, Hale JE, Carmines D, et al. Biomechanical evaluation of early fracture healing in normal and diabetic rats. J Orthop Res 2000;18:126-32
   PubMed Web of Science ®Google Scholar
• Herbsman H, Powers JC, Hirschman A, Shaftan GW. Retardation of fracture healing in experimental diabetes. J Surg Res 1968;8:424-31
   PubMed Web of Science ®Google Scholar
• Cozen L. Does diabetes delay fracture healing? Clin Orthop Relat Res 1972;82:134-40
   PubMed Web of Science ®Google Scholar
• Loder RT. The influence of diabetes mellitus on the healing of closed fractures. Clin Orthop Relat Res 1988(232):210-16
   PubMed Web of Science ®Google Scholar
• Levin ME, Boisseau VC, Avioli LV. Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. N Engl J Med 1976;294:241-5
   PubMed Web of Science ®Google Scholar
• Hernandez RK, Do TP, Critchlow CW, et al. Patient-related risk factors for fracture-healing complications in the United Kingdom General Practice Research Database. Acta Orthop 2012;83:653-60
   PubMed Web of Science ®Google Scholar
• Shibuya N, Humphers JM, Fluhman BL, Jupiter DC. Factors Associated with Nonunion, Delayed Union, and Malunion in Foot and Ankle Surgery in Diabetic Patients. J Foot Ankle Surg 2013;52:207-11
   PubMed Web of Science ®Google Scholar
• Simpson CM, Calori GM, Giannoudis PV. Diabetes and fracture healing: the skeletal effects of diabetic drugs. Expert Opin Drug Saf 2012;11:215-20
   PubMed Web of Science ®Google Scholar
• Schürch MA, Rizzoli R, Slosman D, et al. Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998;128:801-9
   PubMed Web of Science ®Google Scholar
• Dayer R, Rizzoli R, Kaelin A, Ammann P. Low protein intake is associated with impaired titanium implant osseointegration. J Bone Miner Res 2006;21:258-64
   PubMed Web of Science ®Google Scholar
• Dayer R, Brennan TC, Rizzoli R, Ammann P. PTH improves titanium implant fixation more than pamidronate or renutrition in osteopenic rats chronically fed a low protein diet. Osteoporos Int 2010;21:957-67
   PubMed Web of Science ®Google Scholar
• Simon AM, Manigrasso MB, O’Connor JP. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 2002;17:963-76
   PubMed Web of Science ®Google Scholar
• Gerstenfeld LC, Thiede M, Seibert K, et al. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res 2003;21:670-5
   PubMed Web of Science ®Google Scholar
• Murnaghan M, Li G, Marsh DR. Nonsteroidal anti-inflammatory drug-induced fracture nonunion: an inhibition of angiogenesis? J Bone Joint Surg Am 2006;88(Suppl 3):140-7
   PubMed Web of Science ®Google Scholar
• Fransen M, Neal B. Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty. Cochrane Database Syst Rev 2004(3):CD001160
   Google Scholar
• Burd TA, Hughes MS, Anglen JO. Heterotopic ossification prophylaxis with indomethacin increases the risk of long-bone nonunion. J Bone Joint Surg Br 2003;85:700-5
   PubMed Web of Science ®Google Scholar
• Giannoudis PV, MacDonald DA, Matthews SJ, et al. Nonunion of the femoral diaphysis. The influence of reaming and non-steroidal anti-inflammatory drugs. J Bone Joint Surg Br 2000;82:655-8
   PubMed Web of Science ®Google Scholar
• Aspenberg P. Drugs and fracture repair. Acta Orthop 2005;76:741-8
   PubMed Web of Science ®Google Scholar
• Chung UI, Lanske B, Lee K, et al. The parathyroid hormone/parathyroid hormone-related peptide receptor coordinates endochondral bone development by directly controlling chondrocyte differentiation. Proc Natl Acad Sci USA 1998;95:13030-5
   PubMed Web of Science ®Google Scholar
• Kobayashi T. Indian hedgehog stimulates periarticular chondrocyte differentiation to regulate growth plate length independently of PTHrP. J Clin Invest 2005;115:1734-42
   PubMed Web of Science ®Google Scholar
• Andreassen TT, Ejersted C, Oxlund H. Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res 1999;14:960-8
   PubMed Web of Science ®Google Scholar
• Holzer G, Majeska RJ, Lundy MW, et al. Parathyroid hormone enhances fracture healing. A preliminary report. Clin Orthop Relat Res 1999(366):258-63
   PubMed Web of Science ®Google Scholar
• Komatsubara S, Mori S, Mashiba T, et al. Human parathyroid hormone (1–34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora. Bone 2005;36:678-87
   PubMed Web of Science ®Google Scholar
• Tsiridis E, Morgan EF, Bancroft JM, et al. Effects of OP-1 and PTH in a new experimental model for the study of metaphyseal bone healing. J Orthop Res 2007;25:1193-203
   PubMed Web of Science ®Google Scholar
• Mognetti B, Marino S, Barberis A, et al. Experimental stimulation of bone healing with teriparatide: histomorphometric and microhardness analysis in a mouse model of closed fracture. Calcif Tissue Int 2011;89:163-71
   PubMed Web of Science ®Google Scholar
• Nakajima A, Shimoji N, Shiomi K, et al. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). J Bone Miner Res 2002;17:2038-47
   PubMed Web of Science ®Google Scholar
• Alkhiary YM, Gerstenfeld LC, Krall E, et al. Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). J Bone Joint Surg Am 2005;87:731-41
   PubMed Web of Science ®Google Scholar
• Manabe T, Mori S, Mashiba T, et al. Human parathyroid hormone (1–34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys. Bone 2007;40:1475-82
   PubMed Web of Science ®Google Scholar
• Kim HW, Jahng JS. Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized rats. Iowa Orthop J 1999;19:71-7
   PubMedGoogle Scholar
• Habermann B, Kafchitsas K, Olender G, et al. Strontium ranelate enhances callus strength more than PTH 1-34 in an osteoporotic rat model of fracture healing. Calcif Tissue Int 2009;86:82-9
   PubMed Web of Science ®Google Scholar
• Komrakova M, Stuermer EK, Werner C, et al. Effect of human parathyroid hormone hPTH (1–34) applied at different regimes on fracture healing and muscle in ovariectomized and healthy rats. Bone 2010;47:480-92
   PubMed Web of Science ®Google Scholar
• Ellegaard M, Kringelbach T, Syberg S, et al. The effect of PTH(1-34) on fracture healing during different loading conditions. J Bone Miner Res 2013;28:2145-55
   PubMed Web of Science ®Google Scholar
• Hamann C, Picke A-K, Campbell GM, et al. Effects of parathyroid hormone on bone mass, bone strength, and bone regeneration in male rats with type 2 diabetes mellitus. Endocrinology 2014;155:1197-206
   PubMed Web of Science ®Google Scholar
• Tägil M, McDonald MM, Morse A, et al. Intermittent PTH(1–34) does not increase union rates in open rat femoral fractures and exhibits attenuated anabolic effects compared to closed fractures. Bone 2010;46:852-9
   PubMed Web of Science ®Google Scholar
• Lin EA, Liu C-J, Monroy A, et al. Prevention of atrophic nonunion by the systemic administration of parathyroid hormone (PTH 1-34) in an experimental animal model. J Orthop Trauma 2012;26:719-23
   PubMed Web of Science ®Google Scholar
• Aspenberg P, Wermelin K, Tengwall P, Fahlgren A. Additive effects of PTH and bisphosphonates on the bone healing response to metaphyseal implants in rats. Acta Orthop 2008;79:111-15
   PubMed Web of Science ®Google Scholar
• Li YF, Zhou CC, Li JH, et al. The effects of combined human parathyroid hormone (1-34) and zoledronic acid treatment on fracture healing in osteoporotic rats. Osteoporos Int 2011;23:1463-74
   PubMed Web of Science ®Google Scholar
• Zhang D, Potty A, Vyas P, Lane J. The role of recombinant PTH in human fracture healing: a systematic review. J Orthop Trauma 2014;28:57-62
   PubMed Web of Science ®Google Scholar
• Chintamaneni S, Finzel K, Gruber BL. Successful treatment of sternal fracture nonunion with teriparatide. Osteoporos Int 2009;21:1059-63
   PubMed Web of Science ®Google Scholar
• Oteo-Alvaro Á, Moreno EM. Atrophyc humeral shaft nonunion treated with teriparatide (rh PTH 1-34): a case report. J Shoulder Elbow Surg 2010;19:e22-8
   PubMedGoogle Scholar
• Borges JL, Freitas A, Bilezikian JP. Accelerated fracture healing with teriparatide. Arq Bras Endocrinol Metabol 2013;57:153-6
   PubMed Web of Science ®Google Scholar
• Rubery PT, Bukata SV. Teriparatide may accelerate healing in delayed unions of type III odontoid fractures: a report of 3 cases. J Spinal Disord Tech 2010;23:151-5
   PubMed Web of Science ®Google Scholar
• Lee Y-K, Ha Y-C, Koo K-H. Teriparatide, a nonsurgical solution for femoral nonunion? A report of three cases. Osteoporos Int 2012;23:2897-900
   PubMed Web of Science ®Google Scholar
• Aspenberg P, Genant HK, Johansson T, et al. Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res 2009;25:404-14
   Web of Science ®Google Scholar
• Aspenberg P, Johansson T. Teriparatide improves early callus formation in distal radial fractures. Acta Orthop 2010;81:234-6
   PubMed Web of Science ®Google Scholar
• Peichl P, Holzer LA, Maier R, Holzer G. Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women. J Bone Joint Surg Am 2011;93:1583-7
   PubMed Web of Science ®Google Scholar
• Tamai K, Takamatsu K, Kazuki K. Successful treatment of nonunion with teriparatide after failed ankle arthrodesis for Charcot arthropathy. Osteoporos Int 2013;24:2729-32
   PubMed Web of Science ®Google Scholar
• Raghavan P, Christofides E. Role of teriparatide in accelerating metatarsal stress fracture healing: a case series and review of literature. Clin Med Insights Endocrinol Diabetes 2012;5:39-45
   PubMedGoogle Scholar
• Malhotra R, Meena S, Digge VK. Tensile type of stress fracture neck of femur: role of teriparatide in the process of healing in a high risk patient for impaired healing of fracture. Clin Cases Miner Bone Metab 2013;10:210-12
   Google Scholar
• Whyte MP, Mumm S, Deal C. Adult hypophosphatasia treated with teriparatide. J Clin Endocrinol Metab 2007;92:1203-8
   PubMed Web of Science ®Google Scholar
• Chiang CY, Zebaze RM, Ghasem-Zadeh A, et al. Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy. Bone 2013;52:360-5
   PubMed Web of Science ®Google Scholar
• Huang H-T, Kang L, Huang P-J, et al. Successful teriparatide treatment of atypical fracture after long-term use of alendronate without surgical procedure in a postmenopausal woman. Menopause 2012;19:1360-3
   PubMed Web of Science ®Google Scholar
• Oteo-Álvaro Á, Matas JA, Alonso-Farto JC. Teriparatide (rh [1-34] PTH) improved osteointegration of a hemiarthroplasty with signs of aseptic loosening. Orthopedics 2011;34:e574-7
   Google Scholar
• Tachiiri H, Okuda Y, Yamasaki T, Kusakabe T. Weekly teriparatide administration for the treatment of delayed union: a report of two cases. Arch Osteoporos 2014;9:179
   PubMedGoogle Scholar